Non-Hodgkin's Lymphoma

Kiadis Pharma Announces Promising Phase II Clinical Trial Results ...
In the non-randomized open label study 25 patients, each of whom had
reached end stage Non-Hodgkin's lymphoma, ... This is potentially a
breakthrough achievement for patients suffering from Non-Hodgkin's lymphoma
as well as their ...
<http://usstock.jrj.com.cn/news/2007-08-31/000002620954.html>

此 出现新的结果时 Google 快讯由 Google 提供...
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
取消此 Google 快讯:
http://www.google.com/alerts/remove?s=EAAAANSQSYkTQnzUuyzO0SiyL5o&hl=zh-CN

创建另一个 Google 快讯:
http://www.google.com/alerts?hl=zh-CN

登录以管理快讯:
http://www.google.com/alerts/manage?hl=zh-CN